Baraliakos X, et al. Long-Term Evaluation of Secukinumab in Ankylosing Spondylitis: 5 Year Efficacy and Safety Results from a Phase 3 Trial. ACR 2018, abstract L13.
ACR Winter Rheumatology Symposium: nieuwe ontwikkelingen in behandelingen
feb 2022 | Artrose, RA, Spondyloartritis, Vasculaire geneeskunde